B M Fendly
- Oncology top 0.5%
- Molecular Biology top 2%
- Radiology, Nuclear Medicine and Imaging top 0.2%
- Immunology top 2%
- Immunology and Allergy top 0.5%
- Co-authors
- H. Michael ShepardGail D. Lewis PhillipsAxel UllrichMarcy WingetDennis J. SlamonLeonard G. PrestaJanusz RakPatricia Rockwell
- Topics
- Monoclonal and Polyclonal Antibodies Research (34 papers)HER2/EGFR in Cancer Research (21 papers)Glycosylation and Glycoproteins Research (12 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
B M Fendly
58 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 3.9k
- Molecular Biology 3.5k
- Radiology, Nuclear Medicine and Imaging 3.0k
- Immunology 1.5k
- Immunology and Allergy 771
Countries citing papers authored by B M Fendly
This map shows the geographic impact of B M Fendly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B M Fendly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B M Fendly more than expected).
Fields of papers citing papers by B M Fendly
This network shows the impact of papers produced by B M Fendly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B M Fendly. The network helps show where B M Fendly may publish in the future.
Co-authorship network of co-authors of B M Fendly
This figure shows the co-authorship network connecting the top 25 collaborators of B M Fendly. A scholar is included among the top collaborators of B M Fendly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B M Fendly. B M Fendly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 71 | |
| 3 | Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.breakdown → | 679 |
| 4 | 43 | |
| 5 | 18 | |
| 6 | 24 | |
| 7 | 144 | |
| 8 | Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. | 362 |
| 9 | 406 | |
| 10 | 45 | |
| 11 | 31 | |
| 12 | Radiolabeled antibody targeting of the HER-2/neu oncoprotein. | 98 |
| 13 | 26 | |
| 14 | 186 | |
| 15 | Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. | 348 |
| 16 | The extracellular domain of HER2/neu is a potential immunogen for active specific immunotherapy of breast cancer. | 39 |
| 17 | p185 HER2 Monoclonal Antibody Has Antiproliferative Effects In Vitro and Sensitizes Human Breast Tumor Cells to Tumor Necrosis Factorbreakdown → | 559 |
| 18 | 52 | |
| 19 | 14 | |
| 20 | 2 |
About B M Fendly
B M Fendly is a scholar working on Immunology and Allergy, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 59 papers that have together received 7.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (34 papers), HER2/EGFR in Cancer Research (21 papers) and Glycosylation and Glycoproteins Research (12 papers). The work is most often cited by research in Oncology (3.9k citations), Radiology, Nuclear Medicine and Imaging (3.0k citations) and Immunology and Allergy (771 citations). B M Fendly has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include H. Michael Shepard, Gail D. Lewis Phillips, Axel Ullrich, Marcy Winget, Dennis J. Slamon, Leonard G. Presta, Janusz Rak, Patricia Rockwell, Neil I. Goldstein and Robert S. Kerbel. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.